Statistics
Publications
16
Citations
991
H-Index
13
Active since
2018
Bo Hao is an author at Wuhan University specializing in medicine, oncology, and molecular oncology.
Publications per year
2018–2024
16
16
Tislelizumab: A Modified Anti-tumor Programmed Death Receptor 1 Antibody
Lin Zhang, Zhihua Geng, Bo Hao et al. · Cancer Control · 2022 · 83 citations · Full text
Medicine, Oncology, Pharmacology +17
Role of TLR4 as a prognostic factor for survival in various cancers: a meta-analysis
Bo Hao, Zhen Chen, Baochen Bi et al. · Oncotarget · 2018 · 42 citations · Full text
Medicine, Immunology, Oncology +10
1–5 of 16